Board of Directors
Officers
Advisory Board
Board of Directors
- Daniel N. Chicoine, CA - Chairman & Co-Chief Executive
Officer
Since 1982, Mr. Chicoine has held various positions at the Magna group of companies, including
President and CEO of Atoma International Inc. While Mr. Chicoine was the CEO of Atoma, he succeeded
in growing its business from $300 million per annum to $1 billion and effected a major restructuring.
In May 1994, Mr. Chicoine formed Triam Automotive Inc., an automobile parts supplier, with other former
executives of Magna and, in July 1994, was instrumental in assisting the company in completing an initial
public offering. While at Triam, he acted as Vice Chairman in charge of sales. After leaving Triam in 1996,
Mr. Chicoine, along with two other former executives of Magna, formed Nighthawk Investments, a small investment
company. Mr. Chicoine has also served as the President of PowerCart Systems Inc., a Markham-based private company
that designs and manufactures battery-equipped workstations that power devices with wireless communication capability.
Mr. Chicoine is a chartered accountant by profession.
- David A. Copeland, CA - Chair of the Audit Committee, Lead Director
Mr. Copeland was the former President and Chief Operating Officer, Triam Automotive Inc., an automobile parts supplier.
Prior to Triam, Mr. Copeland was Chief Financial Officer of Magna International Inc. and President
and Chief Operating Officer of the Cosma Group of Magna. He is currently an active investor in early
stage companies. His background includes practicing as a chartered accountant and a focus on business
valuation and mergers and acquisitions.
- Anthony E. Dobranowski, CA, MBA
Private Business Consultant. Mr. Dobranowski
retired from Magna International Inc., a global automotive parts supplier,
in 2007. During his employment with Magna, Mr. Dobranowski was most recently
a Vice President of Magna, and prior to that held various executive
positions (Vice Chairman, President and CFO) at Tesma International Inc., a
publicly traded Magna subsidiary. He was instrumental in
the initial public offering of Tesma in 1995, and was involved in all aspects
of Tesma's growth, with particular emphasis on financing, investor relations and M&A
activity. Previous to that, Mr. Dobranowski held various senior management positions
with other Magna companies. Mr. Dobranowski holds an MBA from the University of Toronto
and is also a chartered accountant.
- Dr. Henrich R.K. Guntermann, MD, MSc - President, Europe &
Immunology Group
President and CEO, Nuvo Research Inc. Dr. Guntermann has more than 15 years of
experience in the life sciences sector (including business development, restructuring
and corporate financing). With a group of distinguished life sciences entrepreneurs, he
founded BioAlliance AG, a German-based life sciences private equity and consulting firm.
BioAlliance was formed to capitalize on the early stage development of the life sciences
industry in the European Union, by developing life sciences companies and leveraging their
technologies and products worldwide. Through its established international network, it
brings together life sciences companies in the United States, Asia and Europe to foster growth
through alliances. In addition, BioAlliance consults for international life sciences
companies (pharmaceutical, medical devices, diagnostics and agro-biotech) in different
stages of development, including large scale players in the life sciences sector and public
institutions, such as city and state governments, the European Commission and the United
Nations Industry Development Organization (UNIDO). Dr. Guntermann received his medical
doctorate at the Philipps-University in Marburg, Germany. He also received a Masters of
Science in Biology, with specialization in pharmacology/toxicology and human genetics.
- Dr. Klaus von Lindeiner, Dr en droit
Private business consultant. Prior to his retirement in 2000, Mr. von
Lindeiner served as a senior executive for various European multinationals,
including Wacker-Chemie GmbH, Lurgi GmbH and Metallgesellschaft AG. Previously,
Mr. von Lindeiner worked as a legal advisor to the United Nations, Office of the
High Commissioner for Refugees, as well as in the Organizational Committee for the
1972 Munich Olympic Games. He has served as a member of the regional advisory boards
of Deutsche Bank AG, Allianz Insurance AG, and Dresdner Bank AG. He has also served
as a director on the boards of GEFIU, Power Paper Ltd. and OXO Chemie AG. Currently,
Mr. von Lindeiner serves as a member of the Supervisory Board of Bayerische Landesbank
and the Advisory Board of Golding Capital Partners. Mr. von Lindeiner has a professional legal background with a doctorate in international law from
the University of Geneva/Switzerland.
- John C. London, LLB, LLM - President &
Co-Chief Executive Officer
Mr. London is a graduate of the University of Western Ontario law school and holds a Masters of Law Degree from University College London. He was a partner with the Toronto law firm of Strathy, Archibald and Seagram (now Gowlings) where he practiced from 1981 to 1988. In 1988, Mr. London joined Magna International Inc., one of the world's largest automotive parts suppliers. From 1988 to 1993, he was Executive Vice-President and General Counsel at Atoma International Inc., Magna's interior systems group. In 1994, Mr. London co-founded Triam Automotive Inc., a private auto parts supplier, where he served as Executive Vice-President. Mr. London and his partners took Triam public and sold it to Magna in 1998. In 1997 Mr. London co-founded Nighthawk Investments, a private investment firm. From 2002 to 2005, Mr. London was President and Chief Executive Officer of Powercart Systems Inc. a private company that designs and manufactures battery equipped workstations that power devices with wireless communication capability.
- Dr. Jacques Messier, DVM, MBA - Chair of the Compensation and Corporate Governance Committee
Director of the Veterinary Teaching Hospital at the University of
Saskatchewan. Most recently Dr. Messier was the Chief Executive Officer, The Semex Alliance, a partnership specializing in the development and marketing
of high quality genetic technologies, products and services to benefit livestock producers around
the world. Previously, Dr. Messier was involved in management consulting in a number of specialized
assignments pulling from his experience from many different business sectors. From 1995 to 2001 Dr. Messier
held various positions at Novopharm Ltd. a generic pharmaceutical company, including President and Chief
Executive Officer. Dr. Messier was Chief Operating Officer of publicly-traded KV Pharmaceutical Company
from 2001 to 2003. Dr. Messier has also held a variety of management positions with Agriculture Canada and
Health Welfare, including the Director of the Bureau of Human Prescription Drugs. He started his career as
a Doctor of Veterinary Medicine, and practiced large animal medicine at his veterinary clinic in Saskatchewan
for six years before joining Agriculture Canada. Dr. Messier also holds an MBA from the University of Western Ontario.
|
|
